Skip to main content
SpringerLink
Log in

Temporary suspension of Rotarix in the US

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.Components of extraneous virus detected in rotarix vaccine; No known safety risk. Media Release: 22 Mar 2010. Available from: URL: http://www.fda.gov

  2. GlaxoSmithKline statement on new information relating to manufacture of rotarix (rotavirus vaccine). Media Release: 22 Mar 2010. Available from: URL: http://www.gsk.com

  3. European Medicines Agency.European Medicines Agency statement on new information on Rotarix oral vaccine. Media Release: 22 Mar 2010. Available from: URL: http://www.ema.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Temporary suspension of Rotarix in the US. React. Wkly. 1294, 2 (2010). https://doi.org/10.2165/00128415-201012940-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201012940-00002

Keywords

Search

Navigation